Shoulder replacement HES cohort

Serious adverse events and lifetime risk of reoperation after elective shoulder replacement: population based cohort study using hospital episode statistics for England.

Craig RS, Lane JCE, Carr AJ, et al. BMJ (Clinical research ed.) 2019 · PMID 30786996 · doi:10.1136/bmj.l298

Registry studyPrognosisShoulderCitation checked

Question: What are the risks of serious adverse events and lifetime revision after elective shoulder replacement in England?
Design: Population-based cohort study using Hospital Episode Statistics linked to mortality data.
Patients: Adults aged 50 and over having elective shoulder replacement for arthritis in NHS England.
Intervention: Elective shoulder replacement (total, reverse or hemiarthroplasty)
Comparison: Comparisons across age, sex and implant type
Primary outcome: Lifetime risk of revision; serious adverse events at 30 and 90 days
Key result: Serious adverse events were associated with older age, comorbidity and male sex, while lifetime revision risk was greatest in younger patients, particularly younger men, with most revisions occurring in the early years after surgery.
Limitations: Administrative data lack functional outcomes and depend on coding accuracy.
Impact on practice: Provides UK figures for consent conversations, highlighting greater lifetime revision risk for younger patients considering shoulder replacement.

Practise 2 questions on this paper →Read the paper ↗